This inventor holds 29 USPTO granted patents and 10 published patent applications, plus 3 CIPO patents and 6 EPO patents, primarily in Protein Production. Top assignees: E.i. Dupont De Nemours and Company, Danisco US Inc., Butamax Advanced Biofuels LLC. Active years: 2010-2026.
Location History:
- Drexel Hill, PA (US) (2010 - 2011)
- Wilmington, DE (US) (2011 - 2024)
Company Filing History:
17 out of 16,339 
6 out of 485 
4 out of 125 
Years Active: 2010-2026
Areas of Expertise:
Title: **Innovative Contributions of Hongxian He in Biotechnology**
Introduction
Hongxian He, based in Wilmington, DE, is a prominent inventor with a robust portfolio of 25 patents. His work primarily focuses on advancing biotechnology, harnessing genetic modification techniques to improve protein production and genome editing methods.
Latest Patents
Among his latest groundbreaking patents, Hongxian He has developed compositions and methods for increased protein production in *Bacillus licheniformis*. This innovative disclosure relates to genetically modified cells and strains derived from parental cells that incorporate a variant rghR2 gene, significantly enhancing their protein production capabilities. Additionally, he has worked on Cas9 variants and methods for genome modification, providing new approaches for modifying target sequences within the genome of various cells and organisms. His Cas systems include Cas endonuclease variants and guide polynucleotide/Cas endonuclease complexes, showcasing his contribution to the field of gene editing.
Career Highlights
Throughout his career, Hongxian He has made significant strides in the biotechnology sector. Notably, he has worked with esteemed companies, including DuPont de Nemours and Company and Butamax Advanced Biofuels LLC. His experience in these organizations has contributed to his expertise and the innovative nature of his patents.
Collaborations
Hongxian He has collaborated with accomplished professionals in the field, including Mark Scott Payne and Yefim Brun. These partnerships highlight his commitment to collective innovation and the exchange of ideas that drive technological advancements.
Conclusion
In summary, Hongxian He stands as a distinguished inventor in biotechnology, with a strong patent portfolio and impactful collaborations. His latest works pave the way for advancements in protein production and gene editing, demonstrating the importance of innovation in the ongoing evolution of biotechnological applications.